2022 marks the tenth year of FAB's establishment. Thanks to the sponsor for their trust, Tiger Group for their support, and FAB employees for their hard work. With the experience of more than 170 clinical medical imaging projects, FAB has successfully submitted over a dozen projects to NMPA, with customer satisfaction up to 96%. Adhering to the tenet of ‘Specialty, Dedication, Integrity’，FAB has completed multiple tough timelines quickly. We all feel very happy when seeing the improvement of the subjects and the prolongation of overall survival. I still consider the next 10 years as a continuation of the golden 10 years of new drug research and development. We hope to continue to make more contributions to the pharmaceutical industry in China and around the world.